Cargando…

Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma

Detalles Bibliográficos
Autores principales: Chappell, Mark C., Pirro, Nancy T., South, Andrew M., Gwathmey, TanYa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878344/
https://www.ncbi.nlm.nih.gov/pubmed/33399002
http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.16724
_version_ 1783650326224568320
author Chappell, Mark C.
Pirro, Nancy T.
South, Andrew M.
Gwathmey, TanYa M.
author_facet Chappell, Mark C.
Pirro, Nancy T.
South, Andrew M.
Gwathmey, TanYa M.
author_sort Chappell, Mark C.
collection PubMed
description
format Online
Article
Text
id pubmed-7878344
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-78783442021-02-22 Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma Chappell, Mark C. Pirro, Nancy T. South, Andrew M. Gwathmey, TanYa M. Hypertension Research Letter Lippincott Williams & Wilkins 2021-01-05 2021-03-03 /pmc/articles/PMC7878344/ /pubmed/33399002 http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.16724 Text en © 2021 American Heart Association, Inc. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Research Letter
Chappell, Mark C.
Pirro, Nancy T.
South, Andrew M.
Gwathmey, TanYa M.
Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma
title Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma
title_full Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma
title_fullStr Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma
title_full_unstemmed Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma
title_short Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma
title_sort concerns on the specificity of commercial elisas for the measurement of angiotensin (1–7) and angiotensin ii in human plasma
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878344/
https://www.ncbi.nlm.nih.gov/pubmed/33399002
http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.16724
work_keys_str_mv AT chappellmarkc concernsonthespecificityofcommercialelisasforthemeasurementofangiotensin17andangiotensiniiinhumanplasma
AT pirronancyt concernsonthespecificityofcommercialelisasforthemeasurementofangiotensin17andangiotensiniiinhumanplasma
AT southandrewm concernsonthespecificityofcommercialelisasforthemeasurementofangiotensin17andangiotensiniiinhumanplasma
AT gwathmeytanyam concernsonthespecificityofcommercialelisasforthemeasurementofangiotensin17andangiotensiniiinhumanplasma